Akihiro Ko
Chief Executive Officer at Elixirgen Therapeutics.
- Baltimore, MD
- Form D signer
- Elixirgen Therapeutics
Raised on Elixirgen Therapeutics filings
$8.2M
of $8.2M offered across 3 Form D filings
- Form D filings
- 3
- Teammates
- 1
- Last filing
- Nov 13, 2025
Company
mRNA therapies for rare diseases and cancer
- Investors
- 2
Elixirgen Therapeutics filings
| Filed | Security | Sold of offered | Filing |
|---|---|---|---|
| Nov 13, 2025 | Security to be acquired | $4M/ $4M | Form D |
| Apr 9, 2025 | Security to be acquired | $3.6M/ $3.6M | Form D |
| Feb 12, 2025 | Security to be acquired | $600K/ $600K | Form D |
